AADI
Closed
Aadi Bioscience Inc
2.22
+0.01 (+0.45%)
Last Update: 21 Nov 2024 00:00:00
Yesterday: 2.21
Day's Range: 2.2 - 2.28
Send
sign up or login to leave a comment!
When Written:
7.19
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company that focuses on the development of precision medicines for the treatment of cancer. The company's lead product candidate, ABI-009, is a nanoparticle albumin-bound mTOR inhibitor that is being evaluated in multiple clinical trials for the treatment of solid tumors. Aadi Bioscience was founded in 2011 and is headquartered in Los Angeles, California. The company is committed to developing innovative therapies that improve the lives of cancer patients.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!